For the Inventor, By the Inventor

Enter assignee name

Burnaby, Canada

Kardium Inc.

USPTO Granted Patents = 167

% Expired Patents = 3.0

EPO Patents = 27

Trademarks = 2

Forward Citations = 3,218

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Daniel Gelbart (52 out of 152 patents)

Saar Moisa (52 out of 53 patents)

Daniel Robert Weinkam (50 out of 50 patents)

4. Douglas Wayne Goertzen (41 out of 41 patents)

5. Fernando Luis De Souza Lopes (33 out of 38 patents)

6. Daniel Martin Reinders (29 out of 29 patents)

7. Samuel Victor Lichtenstein (28 out of 38 patents)

8. Ashkan Sardari (22 out of 22 patents)

9. Peter Josiah Hawes (22 out of 30 patents)

10. Jeffery Charles Brewster (17 out of 17 patents)

11. Roxanne Wai Tak Louie (15 out of 15 patents)

12. Danai Bisalputra (15 out of 16 patents)

13. Michael Hermann Weber (15 out of 15 patents)

14. John Andrew Funk (14 out of 16 patents)

15. Jorge Jaramillo (14 out of 14 patents)

Core Competencies:

Intra-Cardiac Mapping

Catheter Navigation

Transducer Activation

Ablation Systems

High-Density Electrodes

Medical Device Systems

Lumen Fluid Mechanisms

Steerable Catheters

Tissue Ablation

Safety Release Mechanisms

Medical Device Flushing

Bodily Cavities

167 patents: Sort by Forward Citations

1. 12740825 - Systems and methods for treating tissue with pulsed field ablation (2026-09-22),

2. 12728183 - Medical system including steerable catheter and method of manufacturing (2026-09-08),

3. 12702475 - Catheter system (2026-08-11),

4. 12661190 - Systems and methods for facilitating movement efficiency of a medical device within a bodily cavity (2026-06-23),

5. 12599747 - Medical device systems and methods including safety release, lumen fluid-providing mechanisms, or both (2026-04-14),

6. 12599433 - Apparatus and method for intra-cardiac mapping and ablation (2026-04-14),

7. 12575896 - Catheter navigation systems and methods (2026-03-17),

8. 12496127 - High-density electrode-based medical device system (2025-12-16),

9. 12440166 - Systems and methods for facilitating improved transducer-to-tissue contact (2025-10-14),

10. 12434036 - Medical system including steerable catheter (2025-10-07),

11. 12383325 - Enhanced medical device for use in bodily cavities, for example an atrium (2025-08-12),

12. 12383208 - Systems and methods for selecting, activating, or selecting and activating transducers (2025-08-12),

13. 12376796 - Systems and methods for activating transducers (2025-08-05),

14. 12376795 - Systems and methods for activating transducers (2025-08-05),

15. 12349955 - Enhanced medical device for use in bodily cavities, for example an atrium (2025-07-08),

Kardium is a medical technology company that focuses on the development and commercialization of innovative solutions for the treatment of atrial fibrillation (AF), a common and potentially life-threatening heart rhythm disorder. Their flagship product, the Globe Mapping and Ablation System, combines advanced mapping and ablation technologies to deliver efficient and comprehensive therapy for AF. With a commitment to improving patient outcomes, Kardium aims to transform the way AF is treated and bring hope to millions of people worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

167 Patents

#3 in Burnaby

#68 in Canada

#4,929 in the World

Burnaby, Canada

Kardium Inc.

Forward Citations = 3,218

40 inventors:

Daniel Gelbart (52 out of 152 patents)

Saar Moisa (52 out of 53 patents)

Daniel Robert Weinkam (50 out of 50 patents)

4. Douglas Wayne Goertzen (41 out of 41 patents)

5. Fernando Luis De Souza Lopes (33 out of 38 patents)

Please report any incorrect information to [email protected]

Loading…